Gossamer Bio Inc (NASDAQ:GOSS) has a beta value of 1.84 and has seen 2.08 million shares traded in the last trading session. The company, currently valued at $151.11M, closed the last trade at $0.67 per share which meant it -0.30% during that session. The GOSS stock price is -180.6% off its 52-week high price of $1.88 and 32.84% above the 52-week low of $0.45. The 3-month trading volume is 1.36 million shares.

Gossamer Bio Inc (NASDAQ:GOSS) trade information

Sporting -0.30% in the red in last session, the stock has traded in the red over the last five days, when the GOSS stock price touched $0.67 or saw a rise of 19.27%. Year-to-date, Gossamer Bio Inc shares have moved -26.79%, while the 5-day performance has seen it change -14.77%. Over the past 30 days, the shares of Gossamer Bio Inc (NASDAQ:GOSS) have changed -42.91%.

Gossamer Bio Inc (GOSS) estimates and forecasts

Figures show that Gossamer Bio Inc shares have outperformed across the wider relevant industry. The company’s shares have gained 36.33% over the past 6 months, with this year growth rate of 36.44%, compared to 12.90% for the industry. Other than that, the company has, however, increased its growth outlook for the 2024 fiscal year revenue. Growth estimates for the current quarter are 63.50% and 57.80% for the next quarter.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 11.99% over the past 5 years. Earnings growth for 2024 is a modest 35.82% while over the next 5 years, the company’s earnings are expected to increase by 5.20%.

GOSS Dividends

Gossamer Bio Inc is expected to release its next earnings report in May this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.